The Biosimilar Brain: Dr Stanley Hong
This article was originally published in Scrip
Executive Summary
South Korean firm Celltrion Healthcare is a pioneer in the biosimilar space, having launched the world's first monoclonal antibody biosimilar, Remsima (infliximab). The product was rolled out across Europe earlier this year and is currently under review by the US FDA.